Related Experiment Videos
[Male breast cancer]
Wiener Klinische Wochenschrift
|December 6, 1985
Summary
This study analyzed 18 male breast carcinoma patients treated between 1974-1982. Outcomes included a median overall survival of 52 months and a median disease-free interval of 21 months for male breast cancer.
Area of Science:
- Oncology
- Radiotherapy
- Medical Oncology
Context:
- Male breast carcinoma is rare, necessitating specific clinical investigations.
- This study examines treatment outcomes for male breast cancer patients over an 8-year period.
Purpose:
- To report on the treatment and survival outcomes of male patients diagnosed with breast carcinoma.
- To analyze the efficacy of various treatment modalities including radiotherapy and chemo-radiotherapy.
Summary:
- Eighteen male patients with breast carcinoma were treated between 1974 and 1982.
- Treatment included postoperative radiotherapy for 12 patients and management of recurrent/metastatic disease for 4.
- One patient had inflammatory breast cancer treated with chemo-radiotherapy; another had a history of prostate cancer radiotherapy.
- Median overall survival was 52 months, and median disease-free interval was 21 months.
Impact:
- Provides insights into the long-term outcomes for male breast cancer patients.
- Contributes to understanding the role of radiotherapy in managing male breast carcinoma.
- Highlights survival data for a historically treated cohort, aiding comparative analysis.